Want to see TSE:HYTN full AI Analyst Report?
Top Page
HYTN Innovations Inc
(HYTN)
Select Model
Select Model
Rating:46Neutral
Price Target:
C$0.18
▼(-30.38% Downside)
Action:Reiterated
Date:09/26/26
The score is primarily held back by weak financial performance—ongoing losses, cash burn, and negative equity—despite improving trends and solid revenue growth. Technicals are neutral with only modest positive momentum, and valuation is constrained by a negative P/E and no dividend support.
Positive Factors
Revenue Growth
TTM revenue of about $3.8M, up roughly 35%, indicates expanding commercial traction and a growing base from which to build scale. If maintained, this trend can improve operating leverage and support broader commercialization over the next several quarters.
Negative Factors
Unprofitable Operations
Gross profit remains slightly negative, while TTM EBIT and net margins are about -35% and -47%. This shows revenue has not yet translated into sustainable commercial profitability, leaving the company exposed to continued losses until pricing, mix, or costs improve.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
TTM revenue of about $3.8M, up roughly 35%, indicates expanding commercial traction and a growing base from which to build scale. If maintained, this trend can improve operating leverage and support broader commercialization over the next several quarters.
Read all positive factors
HYTN Innovations Inc (HYTN) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$16.30M
Dividend YieldN/A
Average Volume (3M)4.45K
Price to Earnings (P/E)―
Beta (1Y)-1.04
Revenue Growth194.34%
EPS Growth75.23%
CountryCA
Employees7
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Non-Alcoholic
Share Statistics
EPS (TTM)-0.02
Shares Outstanding95,892,105
10 Day Avg. Volume3,007
30 Day Avg. Volume4,446
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)-14.08
Price to Sales (P/S)9.42
P/FCF Ratio-26.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HYTN Innovations Inc Business Overview & Revenue Model
Company Description
HYTN Innovations Inc. is a Canadian firm engaged in the comprehensive development, manufacturing, marketing, distribution, and sale of cannabis products for the recreational adult-use market. The company's future product line is slated to include ...
HYTN Innovations Inc Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
12
Very Negative
Cash Flow
15
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.77M | 1.67M | 851.49K | 763.46K | 696.36K | 0.00 |
| Gross Profit | -104.86K | 93.23K | 287.44K | 91.85K | 121.65K | 0.00 |
| EBITDA | -1.05M | -1.12M | -6.26M | -1.45M | -9.88M | -745.51K |
| Net Income | -1.77M | -1.52M | -6.61M | -2.33M | -17.38M | -959.48K |
Balance Sheet | ||||||
| Total Assets | 2.64M | 3.62M | 2.38M | 2.58M | 3.79M | 2.76M |
| Cash, Cash Equivalents and Short-Term Investments | 80.15K | 345.10K | 256.58K | 187.56K | 1.03M | 264.06K |
| Total Debt | 1.10M | 2.04M | 793.56K | 919.74K | 887.22K | 2.58M |
| Total Liabilities | 4.09M | 4.74M | 2.56M | 2.27M | 1.71M | 2.77M |
| Stockholders Equity | -1.46M | -1.12M | -172.97K | 314.72K | 2.07M | -8.88K |
Cash Flow | ||||||
| Free Cash Flow | -585.93K | -590.49K | -804.21K | -1.18M | -2.38M | -1.67M |
| Operating Cash Flow | -573.45K | -572.27K | -783.36K | -1.18M | -2.16M | -693.52K |
| Investing Cash Flow | -37.16K | -15.92K | 162.67K | -4.10K | 2.19M | -1.02M |
| Financing Cash Flow | 638.11K | 676.12K | 689.71K | 346.17K | 727.93K | 1.80M |
HYTN Innovations Inc Technical Analysis
Negative
0.26
Price Trends
0.15
Positive
0.17
Negative
0.20
Negative
Market Momentum
<0.01
Positive
49.69
Neutral
42.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:HYTN, the sentiment is Negative. The current price of 0.26 is above the 20-day moving average (MA) of 0.19, above the 50-day MA of 0.15, and above the 200-day MA of 0.20, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.69 is Neutral, neither overbought nor oversold. The STOCH value of 42.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:HYTN.
HYTN Innovations Inc Peers Comparison
UnderperformOutperform
Sector (62)
TSE:HYTN
HYTN Innovations Inc
0.19
-0.05
-22.92%
TSE:CGII
CleanGo Innovations
1.21
0.52
75.36%
TSE:HYPE
Hemp for Health Inc
0.16
-0.30
-65.22%
TSE:MUSL
Element Nutritional Sciences Inc
0.03
-0.03
-50.00%
TSE:PTFY
Plantify Foods Inc
0.09
-0.29
-76.84%
HYTN Innovations Inc Corporate Events
Business Operations and StrategyExecutive/Board ChangesM&A Transactions
HYTN to Spin Out Peptide Drug Unit into Peptide Development Labs
Positive
Sep 2, 2026
HYTN Innovations Inc., a pharmaceutical manufacturer of psychoactive and psychotropic products including cannabis-derived cannabinoids, serves federally regulated medical markets globally by deploying pharmaceutical-grade development and GMP manuf...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.